Method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value -9465.55% · OPTIONAL
· Pharmaceutical Preparations
RESEARCH SNAPSHOTJUPITER NEUROSCIENCES, INC.'s latest supported as-filed period reports revenue of $24,245. Every value below links to its SEC accession and metric lineage.
No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value -9465.55% · OPTIONAL
Level · gp.fundamentals.inventory_revenue_ratio
Raw value 558.01% · OPTIONAL
Level · gp.fundamentals.gross_margin
Raw value 86.88% · CORE
Level · gp.fundamentals.operating_margin
Raw value -11313.45% · CORE
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
Raw value 2476.19% · OPTIONAL
Level · gp.fundamentals.sbc_revenue_ratio
Raw value 2025.15% · OPTIONAL
Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
Interpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Operating income changed -21.1% from the comparable as-filed period.
Research & development changed -20.9% from the comparable as-filed period.
Each point keeps the date investors could first observe it and its accession.
JUNS · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001493152-26-041315SEC ↗8-KAug 28, 2026Period Aug 27, 20260001493152-26-040577SEC ↗8-KAug 27, 2026Period Aug 26, 20260001493152-26-040308SEC ↗8-KAug 24, 2026Period Aug 24, 20260001493152-26-039886SEC ↗8-KAug 24, 2026Period Aug 21, 20260001493152-26-039785SEC ↗10-QAug 14, 2026Period Jun 30, 20260001493152-26-038463SEC ↗8-KAug 6, 2026Period Aug 6, 20260001493152-26-036279SEC ↗4Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Jul 31, 2026Filed Aug 5, 2026 | Cutler Andrew JonDirector | Grant Or AwardDirect | 472,222 | $0 | $0 | Form 4 ↗ |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Net income changed -1.0% from the comparable as-filed period.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001493152-26-036161